Cargando…
Treatment of immune thrombocytopenic purpura: focus on eltrombopag
Immune thrombocytopenic purpura (ITP) is a relatively common autoimmune disorder in which antibodies are produced to circulating platelets. Symptoms can be mild, but for most patients the risk of severe bleeding is unacceptable and treatment is required. Glucocorticoids followed by splenectomy had b...
Autor principal: | Rice, Lawrence |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726065/ https://www.ncbi.nlm.nih.gov/pubmed/19707404 |
Ejemplares similares
-
Comparison of Splenectomy and Eltrombopag Treatment in the Second-Line Treatment of Immune Thrombocytopenic Purpura
por: Uğur, Mehmet Can, et al.
Publicado: (2021) -
Eltrombopag for Adults and Children with Immune-Refractory Thrombocytopenic Purpura: A Systematic Review
por: de Barros Torelli, Danielle Francisco Honorato, et al.
Publicado: (2023) -
Eltrombopag – a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations
por: Cook, Lucy, et al.
Publicado: (2010) -
Eltrombopag-Induced Thrombocytosis and Thrombosis in Patients With Antiphospholipid Syndrome and Immune Thrombocytopenic Purpura
por: Oo, Zayar, et al.
Publicado: (2022) -
Acute Myocardial Infarction Due to Eltrombopag Therapy in a Patient with Immune Thrombocytopenic Purpura
por: Sert, Sena, et al.
Publicado: (2017)